Thrivent Financial For Lutherans Astrazeneca PLC Transaction History
Thrivent Financial For Lutherans
- $52.6 Billion
- Q3 2024
A detailed history of Thrivent Financial For Lutherans transactions in Astrazeneca PLC stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 44,455 shares of AZN stock, worth $2.91 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,455
Previous 1,372,805
96.76%
Holding current value
$2.91 Million
Previous $107 Million
96.77%
% of portfolio
0.01%
Previous 0.22%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.11 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.74 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.43 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.41 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.25 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $203B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...